Restricted accessResearch articleFirst published online 2022-7
Intra-articular injection with platelet-rich plasma compared to triamcinolone hexacetonide or saline solution in knee osteoarthritis: A double blinded randomized controlled trial with one year follow-up
To compare the effectiveness of intra-articular injection (IAI) of Platelet-Rich Plasma (PRP) with Triamcinolone Hexacetonide (TH) and Saline Solution (SS), in patients with knee osteoarthritis (OA).
Design
A randomized controlled trial, with blinded patients and assessor.
Setting
Outpatient rheumatology service.
Subjects
Patients with knee osteoarthritis grades II and III.
Interventions
Patients received IAI with PRP, 40 mg TH, or SS.
Methods
Patients were assessed at baseline and after 4, 8, 12 e 52 weeks with: visual analogue scale (VAS) for pain at rest and movement, WOMAC questionnaire, Timed to Up and Go test, 6-min walk test, percentage of improvement, goniometry, quality of life SF-36 questionnaire, Likert scale and Kelgreen & Lawrence (KL) radiographic scale (only at baseline and 52 weeks).
Results
100 patients were studied, with a mean age of 67.13(6.56) years. The TH group was superior for: percentage of improvement (versus SS group from 4 to 52 weeks); WOMAC total and pain (versus PRP group at 4 weeks); and WOMAC stiffness (versus SS group at 12 weeks). The SS group was inferior for WOMAC function (from 8 to 52 weeks). The PRP group showed lowest radiographic progression [TH 17 (51.51%) to 24 (72.72%); SS 17 (51.51%) to 30 (90.90%); PRP 20 (58.82%) to 21 (61.76%)].
Conclusion
The Triamcinolone Hexacetonide group was superior for percentage of improvement and WOMAC, pain and stiffness. For the WOMAC function, the Platelet-Rich Plasma group and Triamcinolone Hexacetonide group were superior to the Saline group. The Platelet-Rich Plasma group showed the lowest radiographic progression at 52 weeks of follow-up.
FelsonDTLawrenceRCDieppePA, et al. Osteoarthritis: new insights. Ann Intern Med2000; 133: 635–646.
2.
ArdenNNevittMC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol2006; 20: 3–25.
3.
BannuruRROsaniMCVaysbrotEE, et al. OARSI Guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage2019; 27: 1578–1589.
4.
HepperCTHalvorsonJJDuncanST, et al. The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies. J Am Acad Orthop Surg2009; 17: 638–646.
5.
JordanKMArdenNKDohertyM, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis2003; 62: 1145–1155.
6.
SampsonSGerhardtMMandelbaumB. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med2008; 1: 165–174.
7.
ParkYGHanSBSongSJ, et al. Platelet-rich plasma therapy for knee joint problems: review of the literature, current practice and legal perspective in Korea. Knee Surg Relat Res2012; 24: 70–78.
8.
KhoshbinALerouxTWassersteinD, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy: The Journal of Arthroscopic and Related Surgery2013; 29: 2037–2048.
9.
ShenLYuanTChenS, et al. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res2017; 12: 16.
10.
YeYZhouXMaoS, et al. Platelet rich plasma versus hyaluronic acid in patients with hip osteoarthritis: a meta-analysis of randomized controlled trials. Int J Surg2018; 53: 79–87.
11.
PatelSDhillonMSAggarwalS, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis. Am J Sports Med2013; 41: 356–364.
12.
LinKYYangCCHsuCJ, et al. Intra-articular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: a randomized, double-blind, triple-parallel, placebo-controlled clinical trial. Arthroscopy. 2019; 35: 106–117.
13.
BennellKLPatersonKLMetcalfBR, et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial. JAMA2021; 326: 2021–2030.
14.
KellgrenJHLawrenceJS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis1957; 16: 494–502.
15.
AltmanRAschEBlochD, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of ostheoarthritis of the knee. Arthritis Rheum1986; 29: 1039–1049.
16.
GargAK. The use of platelet rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update2000; 11: 17.
17.
MarxRGargA. Dental and craniofacial applications of plateletrich plasma. Carol Stream: Quintessence Publishing Co, Inc.; 2005.
18.
BellamyNBuchananWWGoldsmithCH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol1988; 15: 1833–1840.
19.
CiconelliRMFerrazMBSantosW, et al. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (brasil SF-36). Rev Bras Reumatol1999; 39:143–150.
20.
American Thoracic Society (ATS) Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002; 166: 111–117.
21.
PodsiadloDRichardsonS. The timed “up & go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc1991; 39: 142–148.
22.
LikertR. A technique for the measurement of atitudes. New York: The Science Press; 1932. 54. (Arquives of Psychology; 140)
23.
SchulzKFAltmanDG. Moher D, for the CONSORT group. Consort 2010 statement: update guidelines for reporting parallel group randomized trials. Br Med J2010; 340: c332.
CampbellKASaltzmanBMMascarenhasR, et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy2015; 31: 2213–2221.
26.
HuangGHuaSYangT, et al. Platelet-rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors. Exp Ther Med2018; 15: 3096–3102.
27.
GoldbergAMitchellKSoansJ, et al. The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review. J Orthop Surg Res2017; 12:39.
28.
DescalziFUliviVCanceddaR, et al. Platelet-rich plasma exerts antinociceptive activity by a peripheral endocannabinoid related mechanism. Tissue Eng Part A2013; 19: 2120–2129.
29.
SakataRMcNarySMMiyatakeK, et al. Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma. Am J Sports Med. 2015; 43:1467–1473.
30.
AnituaESanchezMNurdenAT, et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford, England) 2007; 46: 1769–1772.
31.
ForoghBMianehsazEShoaeeS, et al. Effect of single injection of platelet-rich plasma in comparison with corticosteroid on knee osteoarthtritis: a double-blind randomized clinical trial. J Sports Med Phys Fitness2016; 56: 901–908.
32.
Joshi-JubertNRodriguezLReverté-VinaixaMM, et al. Platelet-Rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double-blinded clinical trial. Orthop J Sports Med2017; 5(2): 2325967116689386.
33.
CamurcuYSofuHUcpunarH, et al. Single-dose intra-articular corticosteroir injection prior to platelet rich plasma injection resulted in better clinical outcomes in patients with knee osteoarthritis: a piloty-study. J Back Musculoskelet Rehabil2018; 31: 603–610.
34.
HuangYLiuXXuX, et al. Intra-articular injections of platelet-rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis: a prospective randomized controlled study. Orthopade2019; 48: 239–247.
35.
Andrejs Elksniņš-FinogejevsAVidalLPeredistijsA. Intra-articular platelet-rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis: a single-center prospective randomized controlled study with a 1-year follow up. J Orthop Surg Res2020; 15: 57.
36.
FreireMRMSilvaPMCAzevedoAR, et al. Comparative effect between infiltration of platelet rich plasma and the use of corticosteroids in the treatment of knee osteoarthritis: a prospective and randomized clinical trial. Rev Bras Ortop. 2020; 55(5): 551–556.
37.
AltmanRDDevjiTBhandariM, et al. Clinical benefit of intra-articular saline as a comparator in clinical trials of knee osteoarthritis treatments: a systematic review and meta-analysis of randomized trials. Semin Arthritis Rheum2016; 46: 151–159.
38.
SaltzmanBMLerouxTMeyerMA, et al. The therapeutic effect of intra-articular normal saline injections for knee osteoarthritis. Am J Sports Med. 2017; 45: 2647–2653.
39.
GuessHAKleinmanAKusekJW, et al. ed. The science of placebo: toward an interdisciplinary research agenda. London: BMJ Books; 2002.
